Literature DB >> 26310427

GMPPB-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation.

Braden S Jensen1, Tobias Willer2, Dimah N Saade1, Mary O Cox3, Tahseen Mozaffar4, Mena Scavina5, Vikki A Stefans6, Thomas L Winder7,8, Kevin P Campbell2, Steven A Moore3, Katherine D Mathews1.   

Abstract

Mutations in GDP-mannose pyrophosphorylase B (GMPPB), a catalyst for the formation of the sugar donor GDP-mannose, were recently identified as a cause of muscular dystrophy resulting from abnormal glycosylation of α-dystroglycan. In this series, we report nine unrelated individuals with GMPPB-associated dystroglycanopathy. The most mildly affected subject has normal strength at 25 years, whereas three severely affected children presented in infancy with intellectual disability and epilepsy. Muscle biopsies of all subjects are dystrophic with abnormal immunostaining for glycosylated α-dystroglycan. This cohort, together with previously published cases, allows preliminary genotype-phenotype correlations to be made for the emerging GMPPB common variants c.79G>C (p.D27H) and c.860G>A (p.R287Q). We observe that c.79G>C (p.D27H) is associated with a mild limb-girdle muscular dystrophy phenotype, whereas c.860G>A (p.R287Q) is associated with a relatively severe congenital muscular dystrophy typically involving brain development. Sixty-six percent of GMPPB families to date have one of these common variants.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  GMPPB; congenital muscular dystrophy; congenital myasthenic syndrome; dystroglycanopathy; limb-girdle muscular dystrophy

Mesh:

Substances:

Year:  2015        PMID: 26310427      PMCID: PMC4843780          DOI: 10.1002/humu.22898

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  SIFT: Predicting amino acid changes that affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

Review 2.  Dystroglycan: from biosynthesis to pathogenesis of human disease.

Authors:  Rita Barresi; Kevin P Campbell
Journal:  J Cell Sci       Date:  2006-01-15       Impact factor: 5.285

3.  Expanding the phenotype of GMPPB mutations.

Authors:  Macarena Cabrera-Serrano; Roula Ghaoui; Gianina Ravenscroft; Russell D Johnsen; Mark R Davis; Alastair Corbett; Stephen Reddel; Carolyn M Sue; Christina Liang; Leigh B Waddell; Simranpreet Kaur; Monkol Lek; Kathryn N North; Daniel G MacArthur; Phillipa J Lamont; Nigel F Clarke; Nigel G Laing
Journal:  Brain       Date:  2015-02-12       Impact factor: 13.501

4.  Limb-girdle muscular dystrophy in the United States.

Authors:  Steven A Moore; Christopher J Shilling; Steven Westra; Cheryl Wall; Matthew P Wicklund; Catherine Stolle; Charlotte A Brown; Daniel E Michele; Federica Piccolo; Thomas L Winder; Aaron Stence; Rita Barresi; Nick King; Wendy King; Julaine Florence; Kevin P Campbell; Gerald M Fenichel; Hansell H Stedman; John T Kissel; Robert C Griggs; Shree Pandya; Katherine D Mathews; Alan Pestronk; Carmen Serrano; Daniel Darvish; Jerry R Mendell
Journal:  J Neuropathol Exp Neurol       Date:  2006-10       Impact factor: 3.685

5.  Congenital muscular dystrophy and generalized epilepsy caused by GMPPB mutations.

Authors:  Alya R Raphael; Julien Couthouis; Sarada Sakamuri; Carly Siskind; Hannes Vogel; John W Day; Aaron D Gitler
Journal:  Brain Res       Date:  2014-04-26       Impact factor: 3.252

6.  Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.

Authors:  Steven A Moore; Fumiaki Saito; Jianguo Chen; Daniel E Michele; Michael D Henry; Albee Messing; Ronald D Cohn; Susan E Ross-Barta; Steve Westra; Roger A Williamson; Toshinori Hoshi; Kevin P Campbell
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

7.  Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.

Authors:  Daniel E Michele; Rita Barresi; Motoi Kanagawa; Fumiaki Saito; Ronald D Cohn; Jakob S Satz; James Dollar; Ichizo Nishino; Richard I Kelley; Hannu Somer; Volker Straub; Katherine D Mathews; Steven A Moore; Kevin P Campbell
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

8.  Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.

Authors:  Katsiaryna Belaya; Pedro M Rodríguez Cruz; Wei Wei Liu; Susan Maxwell; Simon McGowan; Maria E Farrugia; Richard Petty; Timothy J Walls; Maryam Sedghi; Keivan Basiri; Wyatt W Yue; Anna Sarkozy; Marta Bertoli; Matthew Pitt; Robin Kennett; Andrew Schaefer; Kate Bushby; Matt Parton; Hanns Lochmüller; Jacqueline Palace; Francesco Muntoni; David Beeson
Journal:  Brain       Date:  2015-06-30       Impact factor: 13.501

9.  Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization.

Authors:  Fumiaki Saito; Steven A Moore; Rita Barresi; Michael D Henry; Albee Messing; Susan E Ross-Barta; Ronald D Cohn; Roger A Williamson; Kathleen A Sluka; Diane L Sherman; Peter J Brophy; James D Schmelzer; Phillip A Low; Lawrence Wrabetz; M Laura Feltri; Kevin P Campbell
Journal:  Neuron       Date:  2003-06-05       Impact factor: 17.173

10.  Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.

Authors:  Caroline Godfrey; Emma Clement; Rachael Mein; Martin Brockington; Janine Smith; Beril Talim; Volker Straub; Stephanie Robb; Ros Quinlivan; Lucy Feng; Cecilia Jimenez-Mallebrera; Eugenio Mercuri; Adnan Y Manzur; Maria Kinali; Silvia Torelli; Susan C Brown; Caroline A Sewry; Kate Bushby; Haluk Topaloglu; Kathryn North; Stephen Abbs; Francesco Muntoni
Journal:  Brain       Date:  2007-09-18       Impact factor: 13.501

View more
  19 in total

1.  GMPPA defects cause a neuromuscular disorder with α-dystroglycan hyperglycosylation.

Authors:  Patricia Franzka; Henriette Henze; M Juliane Jung; Svenja Caren Schüler; Sonnhild Mittag; Karina Biskup; Lutz Liebmann; Takfarinas Kentache; José Morales; Braulio Martínez; Istvan Katona; Tanja Herrmann; Antje-Kathrin Huebner; J Christopher Hennings; Susann Groth; Lennart Gresing; Rüdiger Horstkorte; Thorsten Marquardt; Joachim Weis; Christoph Kaether; Osvaldo M Mutchinick; Alessandro Ori; Otmar Huber; Véronique Blanchard; Julia von Maltzahn; Christian A Hübner
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

2.  Mutations in GMPPB Presenting with Pseudometabolic Myopathy.

Authors:  Chiara Panicucci; Chiara Fiorillo; Francesca Moro; Guja Astrea; Giacomo Brisca; Federica Trucco; Marina Pedemonte; Paola Lanteri; Lucia Sciarretta; Carlo Minetti; Filippo M Santorelli; Claudio Bruno
Journal:  JIMD Rep       Date:  2017-04-30

Review 3.  The role of protein glycosylation in muscle diseases.

Authors:  Kai Dang; Shanfeng Jiang; Yuan Gao; Airong Qian
Journal:  Mol Biol Rep       Date:  2022-04-15       Impact factor: 2.742

4.  Comparison of brain MRI findings with language and motor function in the dystroglycanopathies.

Authors:  Brianna N Brun; Shelley R H Mockler; Katie M Laubscher; Carrie M Stephan; Anne M Wallace; Julia A Collison; M Bridget Zimmerman; William B Dobyns; Katherine D Mathews
Journal:  Neurology       Date:  2017-01-13       Impact factor: 9.910

Review 5.  Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview.

Authors:  Malihe Mohamadian; Mandana Rastegar; Negin Pasamanesh; Ata Ghadiri; Pegah Ghandil; Mohsen Naseri
Journal:  J Mol Neurosci       Date:  2021-11-02       Impact factor: 3.444

6.  Muscle involvement in limb-girdle muscular dystrophy with GMPPB deficiency (LGMD2T).

Authors:  S T Oestergaard; T Stojkovic; J R Dahlqvist; C Bouchet-Seraphin; J Nectoux; F Leturcq; M Cossée; G Solé; C Thomsen; T O Krag; J Vissing
Journal:  Neurol Genet       Date:  2016-10-11

7.  TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.

Authors:  Austin A Larson; Peter R Baker; Miroslav P Milev; Craig A Press; Ronald J Sokol; Mary O Cox; Jacqueline K Lekostaj; Aaron A Stence; Aaron D Bossler; Jennifer M Mueller; Keshika Prematilake; Thierry Fotsing Tadjo; Charles A Williams; Michael Sacher; Steven A Moore
Journal:  Skelet Muscle       Date:  2018-05-31       Impact factor: 4.912

8.  A founder mutation in the GMPPB gene [c.1000G > A (p.Asp334Asn)] causes a mild form of limb-girdle muscular dystrophy/congenital myasthenic syndrome (LGMD/CMS) in South Indian patients.

Authors:  Kiran Polavarapu; Aradhna Mathur; Aditi Joshi; Saraswati Nashi; Veeramani Preethish-Kumar; Mainak Bardhan; Pooja Sharma; Shaista Parveen; Malika Seth; Seena Vengalil; Tanushree Chawla; Leena Shingavi; Uzma Shamim; Sushmita Nayak; A Vivekanand; Ana Töpf; Andreas Roos; Rita Horvath; Hanns Lochmüller; Bevinahalli Nandeesh; Gautham Arunachal; Atchayaram Nalini; Mohammed Faruq
Journal:  Neurogenetics       Date:  2021-08-01       Impact factor: 2.660

Review 9.  Molecular and cellular basis of genetically inherited skeletal muscle disorders.

Authors:  James J Dowling; Conrad C Weihl; Melissa J Spencer
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-13       Impact factor: 94.444

10.  A case report: Becker muscular dystrophy presenting with epilepsy and dysgnosia induced by duplication mutation of Dystrophin gene.

Authors:  Jing Miao; Jia-Chun Feng; Dan Zhu; Xue-Fan Yu
Journal:  BMC Neurol       Date:  2016-12-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.